A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19.

Miyazaki T, Hosogaya N, Fukushige Y, Takemori S, Morimoto S, Yamamoto H, Hori M, Ozawa Y, Shiko Y, Inaba Y, Kurokawa T, Hanaoka H, Iwanami S, Kim K, Iwami S, Watashi K, Miyazawa K, Umeyama T, Yamagoe S, Miyazaki Y, Wakita T, Sumiyoshi M, Hirayama T, Izumikawa K, Yanagihara K, Mukae H, Kawasuji H, Yamamoto Y, Tarumoto N, Ishii H, Ohno H, Yatera K, Kakeya H, Kichikawa Y, Kato Y, Matsumoto T, Saito M, Yotsuyanagi H, Kohno S.

Open source

DOI
10.1128/spectrum.04311-22
Published
2023-05-04
Container
Microbiol Spectr
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1128/spectrum.04311-22,
  title = {A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19.},
  author = {Miyazaki T and  Hosogaya N and  Fukushige Y and  Takemori S and  Morimoto S and  Yamamoto H and  Hori M and  Ozawa Y and  Shiko Y and  Inaba Y and  Kurokawa T and  Hanaoka H and  Iwanami S and  Kim K and  Iwami S and  Watashi K and  Miyazawa K and  Umeyama T and  Yamagoe S and  Miyazaki Y and  Wakita T and  Sumiyoshi M and  Hirayama T and  Izumikawa K and  Yanagihara K and  Mukae H and  Kawasuji H and  Yamamoto Y and  Tarumoto N and  Ishii H and  Ohno H and  Yatera K and  Kakeya H and  Kichikawa Y and  Kato Y and  Matsumoto T and  Saito M and  Yotsuyanagi H and  Kohno S.},
  year = {2023},
  journal = {Microbiol Spectr},
  doi = {10.1128/spectrum.04311-22},
  url = {https://doi.org/10.1128/spectrum.04311-22}
}

RIS

TY  - JOUR
TI  - A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19.
AU  - Miyazaki T
AU  -  Hosogaya N
AU  -  Fukushige Y
AU  -  Takemori S
AU  -  Morimoto S
AU  -  Yamamoto H
AU  -  Hori M
AU  -  Ozawa Y
AU  -  Shiko Y
AU  -  Inaba Y
AU  -  Kurokawa T
AU  -  Hanaoka H
AU  -  Iwanami S
AU  -  Kim K
AU  -  Iwami S
AU  -  Watashi K
AU  -  Miyazawa K
AU  -  Umeyama T
AU  -  Yamagoe S
AU  -  Miyazaki Y
AU  -  Wakita T
AU  -  Sumiyoshi M
AU  -  Hirayama T
AU  -  Izumikawa K
AU  -  Yanagihara K
AU  -  Mukae H
AU  -  Kawasuji H
AU  -  Yamamoto Y
AU  -  Tarumoto N
AU  -  Ishii H
AU  -  Ohno H
AU  -  Yatera K
AU  -  Kakeya H
AU  -  Kichikawa Y
AU  -  Kato Y
AU  -  Matsumoto T
AU  -  Saito M
AU  -  Yotsuyanagi H
AU  -  Kohno S.
PY  - 2023
JO  - Microbiol Spectr
DO  - 10.1128/spectrum.04311-22
UR  - https://doi.org/10.1128/spectrum.04311-22
ER  -

APA

T, M., N, H., Y, F., S, T., S, M., H, Y., M, H., Y, O., Y, S., Y, I., T, K., H, H., S, I., K, K., S, I., K, W., K, M., T, U., S, Y., Y, M., T, W., M, S., T, H., K, I., K, Y., H, M., H, K., Y, Y., N, T., H, I., H, O., K, Y., H, K., Y, K., Y, K., T, M., M, S., H, Y., & S., K. (2023). A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19.. Microbiol Spectr. https://doi.org/10.1128/spectrum.04311-22

Source records